Oncimmune buys back EarlyCDT distribution rights for China
Immunodiagnostics group Oncimmune said it had agreed to acquire the intellectual property and distribution rights for its lung-cancer diagnostics technology in China from Genostics Company....
Wed, 05/05/2021 - 09:25